Article
Impact of Azithromycin on the Quorum Sensing-Controlled Proteome of Pseudomonas aeruginosa
25 Jan 2016
Abstract excerpt
The macrolide antibiotic, azithromycin (AZM), has been reported to improve the clinical outcome of cystic fibrosis patients, many of whom are chronically-infected with Pseudomonas aeruginosa. However, the highest clinically-achievable concentrations of this drug are well-below the minimum inhibitory concentration for P. aeruginosa, raising the question of why AZM exhibits therapeutic activity. One possibility...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
